-
2
-
-
0037333666
-
Staging of brain pathology related to sporadic Parkinson's disease
-
DOI 10.1016/S0197-4580(02)00065-9, PII S0197458002000659
-
Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging. 2003;24:197-211. (Pubitemid 36007810)
-
(2003)
Neurobiology of Aging
, vol.24
, Issue.2
, pp. 197-211
-
-
Braak, H.1
Del Tredici, K.2
Rub, U.3
De Vos, R.A.I.4
Jansen Steur, E.N.H.5
Braak, E.6
-
4
-
-
2342619394
-
Effect of Psychiatric and Other Nonmotor Symptoms on Disability in Parkinson's Disease
-
DOI 10.1111/j.1532-5415.2004.52219.x
-
Weintraub D, Morbeg MJ, Duda JE, Katz I, Stern MB. Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease. J Am Geriatr Soc. 2004;52:784-8. (Pubitemid 38596500)
-
(2004)
Journal of the American Geriatrics Society
, vol.52
, Issue.5
, pp. 784-788
-
-
Weintraub, D.1
Moberg, P.J.2
Duda, J.E.3
Katz, I.R.4
Stern, M.B.5
-
5
-
-
0037335814
-
Prevalence and characteristics of dementia in Parkinson disease: An 8-year prospective study
-
DOI 10.1001/archneur.60.3.387
-
Aarsland D, Andersen K, Larsen JP, Lolk A, Kragh-Sorensen P. Prevalence and characteristics of Dementia in Parkinson disease. Arch Neurol. 2003;60:387-92. (Pubitemid 36314364)
-
(2003)
Archives of Neurology
, vol.60
, Issue.3
, pp. 387-392
-
-
Aarsland, D.1
Andersen, K.2
Larsen, J.P.3
Lolk, A.4
Kragh-Sorensen, P.5
-
6
-
-
34447300709
-
A review of cognitive impairments in dementia with Lewy bodies relative to Alzheimer's disease and Parkinson's disease with dementia
-
DOI 10.1016/S0010-9452(08)70489-1
-
Metzler-Baddeley C. A review of cognitive impairments in dementia with Lewy bodies relative to Alzheimer's disease and Parkinson's disease with dementia. Cortex. 2007;43:583-600. (Pubitemid 47050642)
-
(2007)
Cortex
, vol.43
, Issue.5
, pp. 583-600
-
-
Metzler-Baddeley, C.1
-
7
-
-
0019123271
-
Is the mesocortical dopaminergic system involved in Parkinson disease?
-
Javoy-Agid F, Agid Y. Is the mesocortical dopaminergic system Involved in Parkinson's disease? Neurology. 1980;30:1326-30. (Pubitemid 11209189)
-
(1980)
Neurology
, vol.30
, Issue.12
, pp. 1326-1330
-
-
Javoy-Agid, F.1
Agid, Y.2
-
8
-
-
0141725645
-
What causes mental dysfunction in Parkinson's disease?
-
DOI 10.1002/mds.10581
-
Emre M. What causes mental dysfunction in Parkinson's disease? Mov Disord. 2003;18(Suppl 3):S63-S71. (Pubitemid 37185198)
-
(2003)
Movement Disorders
, vol.18
, Issue.SUPPL. 6
-
-
Emre, M.1
-
9
-
-
0037279168
-
Neuropsychological profile of patients with Parkinson's disease without dementia
-
DOI 10.1159/000068483
-
Janvin C, Aarsland D, Larsen JP, Hugdahl K. Neuropsychological profile of patients with Parkinson's disease without dementia. Dement Geriatr Cogn Disord. 2003;15:126-31. (Pubitemid 36206641)
-
(2003)
Dementia and Geriatric Cognitive Disorders
, vol.15
, Issue.3
, pp. 126-131
-
-
Janvin, C.1
Aarsland, D.2
Larsen, J.P.3
Hugdahl, K.4
-
10
-
-
0031060220
-
Cognitive deficits in Parkinson's disease
-
Dubois B, Pillon B. Cognitive deficits in Parkinson's disease. J Neurol. 1997;244:2-8. (Pubitemid 26413891)
-
(1997)
Journal of Neurology
, vol.244
, Issue.1
, pp. 2-8
-
-
Dubois, B.1
Pillon, B.2
-
11
-
-
10044283107
-
Rivastigmine for dementia associated with Parkinson's disease
-
DOI 10.1056/NEJMoa041470
-
Emre M, Aarsland D, Albanese A, Byrne EJ, Deuschl G, de Deyn PP, et al. Rivastigmine for dementia associated with Parkinson's disease. N Engl J Med. 2004;351:2509-18. (Pubitemid 39603164)
-
(2004)
New England Journal of Medicine
, vol.351
, Issue.24
, pp. 2509-2518
-
-
Emre, M.1
Aarsland, D.2
Albanese, A.3
Byrne, E.J.4
Deuschl, G.5
De Deyn, P.P.6
Durif, F.7
Kulisevsky, J.8
Van Laar, T.9
Lees, A.10
Poewe, W.11
Robillard, A.12
Rosa, M.M.13
Wolters, E.14
Quarg, P.15
Tekin, S.16
Lane, R.17
-
12
-
-
80051957021
-
Clinical practice with anti-dementia drugs: A revised (second) consensus statement from the British Association for Psyehopharmacology
-
0269881110387547
-
O'Brien JT, Burns A. Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psyehopharmacology. J Psychopharmacol November 18, 2010 0269881110387547
-
(2010)
J Psychopharmacol November
, vol.18
-
-
O'Brien, J.T.1
Burns, A.2
|